Patients with metastatic non-small cell lung cancer and targetable molecular alterations in Germany. Treatment and first outcome data from the prospective German Registry Platform CRISP (AIO-TRK-0315). 30. September 2019 Griesinger F, Eberhardt WEE, Nusch A, Reiser M, Zahn MO, Marschner N, Jaenicke M, Fleitz A, Spring L, Sahlmann J, Karatas A, Hipper A, Weichert W, Waller CF, Reck M, Christopoulos P, Sebastian M, Thomas M, 2019. Ann Oncol. 2019;30 (suppl. 5)(1552P (ID: 3764)):mdz260.074 Palbociclib plus fulvestrant as second- or later-line therapy for patients with locally advanced, inoperable or metastatic HR+/HER2- breast cancer in Germany: Interim results of the INGE-B phase 2 study. Lüftner D, Welslau M, Liersch R, Deryal M, Brucker C, Rauh J, Welt A, Zaiss M, Sahlmann J, Houet L, Vannier C, Potthoff K, Marschner… Weiterlesen Patients with metastatic non-small cell lung cancer and PD-L1 expression in Germany. Treatment and first outcome from the prospective German Registry Platform CRISP (AIO-TRK-0315). Sebastian M, Eberhardt WEE, Losem C, Bernhardt C, Maintz C, Marschner N, Jaenicke M, Fleitz A, Spring L, Sahlmann J, Karatas A, Hipper A, Weichert… Weiterlesen